Cigarette smoke, but not novel tobacco vapor products, causes epigenetic disruption and cell apoptosis by Hattori Naoko et al.
Biochemistry and Biophysics Reports 24 (2020) 100865
Available online 21 November 2020
2405-5808/© 2020 The Authors. Published by Elsevier B.V. This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).
Cigarette smoke, but not novel tobacco vapor products, causes epigenetic 
disruption and cell apoptosis 
Naoko Hattori a,b, Takeya Nakagawa a,b, Mitsuhiro Yoneda a,b, Kaori Nakagawa a,b, 
Hiromi Hayashida a,b, Takashi Ito a,b,* 
a Nagasaki University Graduate School of Biomedical Sciences, Nagasaki, Japan 
b Department of Biochemistry, Nagasaki University School of Medicine, Nagasaki, Japan   





A B S T R A C T   
Heat-Not-Burn (HNB) products, generating vapor without combusting tobacco leaves, have been developed with 
the expectation that the number and quantity of chemicals in the vapor of these products would be reduced 
compared with the smoke from conventional combustible cigarettes. However, whether the lower chemical 
levels correlate with lower toxicity remains to be determined. 
Here we examined differences in the biological effects of conventional cigarette smoke (CS) and two HNB 
products, Ploom TECH and Ploom TECH+, using the cultured cancer cell line A549 and the normal bronchial 
epithelium cell line BEAS-2B. The conventional CS 3R4F extract (0.5%) markedly decreased cell proliferation of 
both A549 and BEAS-2B cells; however, 0.5% extracts of these commercially available HNB products did not 
affect cell growth. To determine the cause of decreased cell proliferation, a TUNEL assay was performed, and the 
results indicated that apoptosis had occurred in both A549 and BEAS-2B cells at 24 h after exposure to 3R4F. To 
further explore the effect of CS on epigenetics, we performed western blotting to detect histone H2A phos-
phorylation, which is known to affect transcriptional regulation. Only the 3R4F extract decreased histone H2A 
phosphorylation in both A549 and BEAS-2B cells. Next, we examined alterations in gene expression after 
treatment of A549 cells with Ploom TECH, Ploom TECH+, or 3R4F extracts. It was found that 339, 107, and 103 
genes were upregulated more than 2 fold in A549 cells treated with 3R4F, Ploom TECH, or Ploom TECH +
extracts, respectively. Among the 339 genes that were upregulated in response to 3R4F, we focused on EGR1, 
FOS, and FOSB, since they were upregulated more than 100 fold, which was confirmed using RT-qPCR. These 
results suggest that CS, but not HNB products, cause epigenetic disruption and cell apoptosis, possibly by 
elevating transcription of genes such as EGR1.   
1. Introduction 
The use of tobacco-containing vapor products is increasing world-
wide. In addition to e-cigarettes, which produce vapor by heating a 
nicotine-containing liquid, Heat-Not-Burn (HNB) products, in which the 
tobacco is heated without being combusted, have been developed [1]. 
Emissions from HNB products have been reported to contain lower 
levels of harmful chemicals than conventional cigarette smoke (CS), [2]. 
However, whether this reduction of potentially harmful chemicals is 
correlated with decreased toxicity and lower risk for developing chronic 
obstructive pulmonary disease (COPD) or other disorders needs to be 
verified. 
COPD is a chronic, irreversible respiratory disease that is caused by 
an abnormal inflammatory response of the lungs to noxious particles or 
gases, resulting in chronic bronchiolitis and emphysema, which cause 
airflow limitation [3]. Although miscellaneous environmental and ge-
netic risk factors are involved in the pathogenesis of COPD, CS is 
regarded as one of the most important [4]. The primary target of inhaled 
CS is the airway epithelium, which is a barrier to inhaled toxic chem-
icals. Several mechanisms are possible for COPD development, such as 
an influx of inflammatory cells into the airway, resulting in chronic 
inflammation, or an imbalance between proteolysis and anti-proteolysis, 
resulting in lung tissue destruction and oxidative stress. In addition, 
apoptosis of structural cells in the lung is regarded as an important event 
in the pathogenesis of COPD. An increase in apoptotic alveolar epithelial 
and endothelial cells is observed in the lungs of COPD patients, 
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suggesting a role for this process in the destruction of lung tissue and the 
development of emphysema and COPD [5]. 
To understand the mechanisms for how CS contributes to COPD 
development, several approaches have been developed. Capturing the 
smoke emitted from a cigarette by bubbling it through an aqueous so-
lution is one approach. Such preparations (known as smoking extracts) 
have been widely used as sample sources for various purposes, such as in 
vitro assays. That smoking extracts differ from the untreated smoke is a 
limitation. However, in vivo, bronchial epithelial cells are not directly 
exposed to the smoke itself but rather to components that have been 
extracted into biologically secreted fluids. Therefore, in vitro cell culture 
studies using smoke preparations remain important tools in the assess-
ment of CS-induced toxicity [6]. 
In this study we examined differences in the biological effects of 
conventional CS and two commercial HNB products, Ploom TECH and 
Ploom TECH+, using the lung cancer cell line A549 and the normal 
bronchial epithelium cell line BEAS-2B. Conventional 3R4F extracts 
(0.5%) from CS markedly decreased cell proliferation of both A549 and 
BEAS-2B cells, while 0.5% extracts of Ploom TECH or Ploom TECH + did 
not affect cell growth. TUNEL assays indicated that apoptosis was pre-
sent in both A549 and BEAS-2B cells at 24 h after exposure to 3R4F but 
not after exposure to Ploom TECH or Ploom TECH+. Alterations of gene 
expression in A549 cells in which EGR1, FOS, and FOSB genes were 
upregulated by more than 100 fold occurred only after 3R4F treatment. 
These results suggest that CS, but not HNB products, causes epigenetic 
disruption and cell apoptosis, possibly by elevating expression of genes 
such as EGR1. 
2. Material and methods 
2.1. Smoke and aerosol generation 
Smoking extracts were prepared as previously described [1]. Briefly, 
3R4F cigarettes were purchased from the University of Kentucky, Ken-
tucky Tobacco Research and Development Center (Lexington, KY, USA). 
Two commercial HNB products, Ploom TECH and Ploom TECH+, were 
obtained from Japan Tobacco Inc. (Tokyo, Japan). HNB products consist 
of three modules: a puff-activated electrical heating device with a 
rechargeable battery, a cartomizer containing a nicotine-free carrier 
liquid, and a tobacco capsule containing granulated tobacco. Untreated 
3R4F cigarette smoke and aerosols from Ploom TECH or Ploom TECH +
HNB products were generated by machine smoking using Health Canada 
Intense (HCI) puffing conditions (55 mL puff volume, 2-s duration, 30-s 
puff interval, and bell-shaped puff profile). The 3R4F cigarette was 
smoked until the remaining butt length was 35 mm. For the HNB 
products, the total puff number for each aerosol collection per tobacco 
capsule was set at 70, which was based on the product specification. 
Aerosols were resolved in DMSO at a concentration of 40 mg/ml for 
3R4F extract and 100 mg/ml for both Ploom TECH and Ploom TECH +
extracts. 
2.2. Cell culture and growth curve 
A549 and BEAS-2B cells were cultured in a humidified chamber 
(37 ◦C, 5% CO2 in air) with Roswell Park Memorial Institute (RPMI), 
supplemented with 10 μg/ml gentamicin and 10% fetal calf serum (Life 
Technologies). One day before counting, the cells were seeded into 24- 
well plates at a density of 0.4 × 104 cells/cm2. On the next day, the cells 
were treated with 0.5% DMSO, Ploom TECH extract, Ploom TECH +
extract, or 3R4F extract in duplicate, and the day was designated as day 
0. From each well, four images were collected on days 0, 1, 2, and 3, and 
the cells were counted within a 1-mm2 square for each image. 
2.3. Western blotting 
Lysates were prepared using a sodium dodecyl sulfate (SDS) sample 
buffer, separated by SDS-PAGE (7% or 12.5%), transferred to a nitro-
cellulose membrane (Bio-Rad), and blocked with 3% BSA in TBST (Tris- 
buffered saline containing 0.05% Tween-20). To detect cyclin D1 and 
H2ApT120, membranes were incubated with anti-cyclin D1 (Abcam 
Ab134175) or anti-H2ApT120 [7] antibodies, followed by horseradish 
peroxidase-conjugated anti-rabbit antibodies (Sigma cat. no. A0545), 
and the subsequent chemiluminescence was obtained using SuperSignal 
West Femto Maximum Sensitivity Substrate (Thermo Fisher Scientific, 
Waltham, MA). To detect hTBP, membranes were incubated with 
anti-TBP antibodies [8], followed by washing and subsequent incuba-
tion with protein A conjugated with Alexa Fluor™ 647 (Thermo Fisher 
Scientific, Waltham, MA, cat. no. p21462). Fluorescence signals were 
captured by employing a Typhoon™ FLA 9000 imager (GE Healthcare) 
to scan the probed membranes, with the PMT setting set at 1000 V. 
2.4. TUNEL assay and FACS analysis 
A549 and BEAS-2B cells were treated with 1 μM stauropsprine and 
0.5% DMSO, Ploom TECH extract, Ploom TECH + extract, or 3R4F 
extract, as indicated. Twenty-four hours after treatment, the cells were 
subjected to a TUNEL assay according to the manufacturer’s instructions 
(DeadEnd Fluorometric TUNEL System, Promega). A549 and BEAS-2B 
cells were stained with propidium iodide and analyzed using a FACS-
Canto II flow cytometer. 
2.5. RNA-seq 
RNA-seq was performed as previously described [9]. Total RNA was 
extracted using ISOGEN II reagent (Nippon Gene), according to the 
manufacturer’s protocol. RNA quality was confirmed using the Agilent 
RNA 6000 Nano kit with an Agilent 2100 Bioanalyzer instrument 
(Agilent Technologies). RNA-seq libraries were generated using the 
TruSeq Stranded mRNA LT Sample Prep kit (Illumina) and sequenced 
with the MiSeq system (Illumina). Sequences were mapped to the human 
genome (GRCh38) with the Illumina Analysis Pipeline. The gene 
expression level was quantified by the number of uniquely mapped 
reads per kilobase of exon per million mapped reads (RPKM) using the 
Partek® Genomics Suite. Gene expression level determination and gene 
ontology (GO) analysis were also performed with the Partek® Genomics 
Suite. Significantly enriched GO functional groups were defined as 
having an enrichment score ≥3 (P value < 0.05). All RNA-seq data can 
be found online in the NCBI GEO submission (GSE157165). 
2.6. RTqPCR 
cDNA was created from 0.5 μg total RNA using an oligo(dT)primer 
(Life Technologies), random hexamers (Takara), and M-MuLV reverse 
transcriptase (NEB). Using SYBR green and appropriate master-mix re-
agents, real-time RT-PCR was performed with an ABI PRISM 7900HT 
instrument (Applied Biosystems). Target gene expression levels were 
normalized via GAPDH expression, and the relative expression level was 









(forward) 5′- AGTGAGACTGAGGGATCGTAGA-3′, 
(reverse) 5′- GGGGTCGGGGATTCATTGAA-3′; 
GAPDH 
(forward) 5′-GGAGCGAGATCCCTCCAAAAT-3′, 
(reverse) 5′- GGCTGTTGTCATACTTCTCATG -3′. 
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Fig. 1. 3R4F extract but not Ploom TECH or Ploom TECH + extracts repressed cell proliferation in both A549 and BEAS-2B cells. 
A549 cells and BEAS-2B cells were plated at a concentration of 0.4 × 104 cells/cm2 in 24-well plates. Twenty-four hours after plating, DMSO, Ploom TECH extract, 
Ploom TECH + extract, or 3R4F extract were added at a concentration of 0.5% on day 0 in duplicate. For each well, four images from one well were collected on days 
0, 1, 2, and 3. The cells were counted within a 1-mm2 square for each image, and cell growth was evaluated for A549 cells (A) and BEAS-2B cells (C). Representative 
morphology on day 3 for A549 cells (B) and BEAS-2B cells (D) treated with the indicated extracts. Duplicated experiments were done three times, and the results were 
found to be consistent. 
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Fig. 2. 3R4F extract but not the Ploom TECH or Ploom TECH + extracts induced apoptosis in both A549 and BEAS-2B cells. 
A549 (A–F) and BEAS-2B (G–L) cells were untreated (A, G) or treated (B, H) with 1 μM staurosporine, 0.5% DMSO (C, I), 0.5% Ploom TECH extract (D, J), 0.5% 
Ploom TECH + extract (E, K), or 0.5% 3R4F extract (F, L) and analyzed using a flow cytometer after treatment using the DeadEnd™ fluorometric TUNEL system 
according to the manufacturer’s protocol. %AP, the percentage apoptosis, calculated as (P5+P10)/(P4+P5+P6+P7+P10) x 100. 
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Fig. 3. 3R4F extract caused abnormal histone modifications and more gene alterations than the Ploom TECH or Ploom TECH + extracts. 
To HeLa cells (A) and BEAS-2B (B) cells were added 0.25, 0.5, 1, and 2% DMSO, Ploom TECH extract, Ploom TECH + extract, or 3R4F extract. Twenty-four hours 
after treatment, the cells were collected and subjected to western blotting for cyclin D1, H2AT120 phosphorylation (H2ApT120), and TBP. Amido black staining and 
anti-TBP western blotting indicated the amount of sample loaded. Venn diagram representing the overlap among 2-fold-upregulated genes (C) and 100-fold-upregu-
lated genes (D) induced by Ploom TECH extract, Ploom TECH + extract, and 3R4F extract treatment of A549 cells. The numbers of the genes are represented. (E) 
Gene ontology analysis of genes upregulated by treatment with 3R4F extract. 
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Fig. 4. 3R4F extract but not the Ploom TECH or Ploom TECH + extracts caused upregulation of the EGR1, FOS, and FOSB genes. 
(A, B, C) RNA-seq signal tracks around the EGR1, FOS, and FOSB genes in A549 cells, which were collected 4 h after treatment with 2% DMSO, 2% Ploom TECH 
extract, 2% Ploom TECH + extract, or 2% 3R4F extract. (D, E, F) RT-qPCR results for the EGR1, FOS, and FOSB genes using the same RNA. The relative expression 
was determined after adjusting for GAPDH expression and comparing with the DMSO control. 
N. Hattori et al.                                                                                                                                                                                                                                 
Biochemistry and Biophysics Reports 24 (2020) 100865
7
3. Results 
3.1. 3R4F but not Ploom TECH or Ploom TECH + extracts repress cell 
proliferation of both A549 and BEAS-2B cells 
In order to examine the extent to which smoking extracts cause cell 
damage, the cultured cancer cell line A549 and the normal bronchial 
epithelium cell line BEAS-2B were used. Both cell lines were plated at a 
concentration of 0.4 × 104 cells/cm2 using 24-well plates. Twenty-four 
hours after plating, DMSO, Ploom TECH extract, Ploom TECH + extract, 
or 3R4F extract were added at a final concentration of 0.5% on day 0. 
The 3R4F extract markedly repressed cell proliferation of both A549 and 
BEAS-2B cells while killing most of the cells, but neither Ploom TECH 
nor Ploom TECH + affected cell growth (Fig. 1A, C). From the 
morphology on day 3, almost all cells treated with 3R4F extract had died 
(Fig. 1B, D). It was previously reported that a lower concentration of CS 
extract induced apoptosis, and a higher concentration of CS extract 
induced necrosis [10]. Therefore, we examined whether CS extract 
induced apoptosis or necrosis in our assay. 
3.2. 3R4F but not Ploom TECH or Ploom TECH + extracts induced 
apoptosis in both A549 and BEAS-2B cells 
To detect the presence of apoptosis, a TUNEL assay was performed 
(Fig. 2). For a positive control, staurosporine, which is known to induce 
apoptosis, was used. Twenty-four hours after adding 1 μM staurosporine 
with 0.5% DMSO, Ploom TECH extract, Ploom TECH + extract, or 3R4F 
extract, the cells were collected, and DNA fragmentation was examined 
using the DeadEnd Fluorometric TUNEL System, Promega. Apoptosis 
had been induced in ~22% of the A549 lung cancer cells and 90.3% of 
BEAS-2B cells at 24 h after staurosporine treatment when compared 
with no treatment (Fig. 2A, B, G, H). Consistent with previously obser-
vation using a lower concentration of CS extract [10], apoptosis was 
induced in ~98.7% of the A549 lung cancer cells and 100.0% of the 
BEAS-2B cells at 24 h after treatment with 0.5% 3R4F (CS) extract 
(Fig. 2F, L). However, apoptosis was induced in <0.5% of the of the 
A549 lung cancer cells and <0.5% of BEAS-2B cells at 24 h after treat-
ment with 0.5% DMSO, Ploom TECH extract, or Ploom TECH + extract 
(Fig. 2C–E, I-K). These findings corroborate the previous report that 
chemical analysis of the HNB aerosol demonstrated that levels of Hoff-
mann analytes, including acetaldehyde, acrolein, carbon monoxide, 
benzene, 1,3-butadiene, formaldehyde, N-nitrosonornicotine (NNN), 
N-nitrosonornicotine ketone (NNK), and benzo[a]pyrene (B[a]P), were 
substantially lower or below quantifiable levels compared with 3R4F 
(CS) extract. Results from in vitro cell culture experiments clearly 
indicated that, in contrast to 3R4F extract, the Ploom TECH and Ploom 
TECH + extracts failed to induce apoptosis. 
3R4F but not Ploom TECH or Ploom TECH + extracts caused 
abnormal histone modification, which is known to be correlated with 
changes in gene transcription. 
To determine the underlying mechanisms of 3R4F extract-induced 
apoptosis, we investigated histone modification, which is an important 
variable in epigenetics. The histone H2A C-terminus is flexible and 
protrudes from the nucleosome core, as do the histone N-terminal do-
mains. It is known that the C-terminal end of histone H2A and the N- 
terminal end of histone H3 contain the linker DNA entry and exit points, 
suggesting their functional importance [11]. We previously found that 
hVRK1 phosphorylates nucleosomal H2A (T120) around the promoter 
region of genes such as CCND1 and regulates transcription [7,12]. 
Therefore, we investigated histone H2A (T120) phosphorylation and 
cyclin D1 expression using western blotting. Four hours after treatment 
with 0.25, 0.5, 1, or 2% DMSO, Ploom TECH extract, Ploom TECH +
extract, or 3R4F extract, the cells were collected, and western blotting 
was performed. A two-percent 3R4F extract treatment of A549 cells and 
a 1 or 2% 3R4F extract treatment of BEAS-2B cells, but not treatment 
with Ploom TECH or Ploom TECH + extracts, caused a loss of bulk 
histone H2A (T120) phosphorylation (Fig. 3A and B). However, this loss 
of phosphorylation reflects bulk core histone H2A but not H2A around 
the promoter region. Since cyclin D1 is regulated by histone H2A 
phosphorylation of the promoter region, it is possible that loss of bulk 
histone H2A phosphorylation does not reflect the phosphorylation of a 
specific promoter [7]. Although loss of bulk core histone H2A phos-
phorylation is strongly correlated with 3R4F extract treatment, the 
mechanisms of apoptosis induction remain to be determined. 
Treatment with 3R4F extract caused more gene alterations than 
Ploom TECH or Ploom TECH + extracts. 
To investigate the gene alterations that might be correlated with cell 
apoptosis, an RNA-seq experiment was performed after treatment of 
A549 cells with Ploom TECH, Ploom TECH+, or 3R4F extracts. Venn 
diagrams of genes upregulated 2 fold (Fig. 3C) or 100 fold (Fig. 3D) are 
shown. The 3R4F extract caused more gene alterations than Ploom 
TECH or Ploom TECH + extracts. GO analysis of the genes affected by 
3R4F identified genes involved in developmental processes as well as 
growth and reproductive processes (Fig. 3E). Among the genes upre-
gulated 100 fold, only EGR1, FOS, and FOSB showed a significant RNA- 
seq profile (Fig. 4A–C). Expression of these three genes was confirmed 
using RT-qPCR (Fig. 4D–F). 3R4F extract but not Ploom TECH or Ploom 
TECH + extracts caused significant activation of the EGR1, FOS, and 
FOSB genes. Previously, it was found that EGR1 is activated by CS 
extract; however in this experiment we found that EGR1, FOS, and FOSB 
are all activated by 3R4F but not by Ploom TECH or Ploom TECH+. 
4. Discussion 
In this study it was found that conventional cigarette smoke (CS) but 
not the Ploom TECH or Ploom TECH + HNB products cause apoptosis, a 
change in histone H2A phosphorylation that is closely correlated with 
changes in gene expression, and upregulation of the EGR1, FOS, and 
FOSB genes. Among these upregulated genes, we focused on EGR1, since 
it has multiple functions relating to the development of cancer, cardio-
vascular disease, memory and psychiatric disorders, and apoptosis 
[13–17]. For the development of cancer, observation over long periods 
is required, and for cardiovascular disease or memory and psychiatric 
disorders, functional changes need to be assessed in complex organs. By 
contrast, in cultured cell experiments, apoptotic mechanisms, which 
may involve EGR1, can be readily investigated. 
Previously, it was reported that, in human lung fibroblasts, CS 
extract stimulates EGR1 expression and subsequent metalloproteinase 2 
(MMP-2) activation. These results support the hypotheses that per-
turbing the balance of protease–antiprotease activity may result in the 
destruction of the alveolar septal architecture and the development of 
CS-related COPD [18]. On the other hand, it has also been reported that 
EGR1 induces apoptosis in multiple situations [19–22]. Among several 
mechanisms of COPD development, the apoptosis of structural cells in 
the lung is regarded as an important event in its pathogenesis [5,23,24]. 
In either case, EGR1 upregulation by CS may play a role in the devel-
opment of COPD. 
This report, that cigarette smoke (CS) but not Ploom TECH or Ploom 
TECH + HNB products causes apoptosis and a change in transcription- 
related histone modifications and is highly correlated with upregula-
tion of EGR1, suggests that CS, but not HNB products, causes COPD via 
apoptotic mechanisms. However, this suggestion is based on in vitro 
experiments; to make a stronger conclusion, in vivo animal experiments 
or human clinical trials would be required. 
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